Leight v. Osteosymbionics, L.L.C.

2017 Ohio 5749, 94 N.E.3d 995
CourtOhio Court of Appeals
DecidedJuly 6, 2017
Docket105101
StatusPublished
Cited by3 cases

This text of 2017 Ohio 5749 (Leight v. Osteosymbionics, L.L.C.) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Leight v. Osteosymbionics, L.L.C., 2017 Ohio 5749, 94 N.E.3d 995 (Ohio Ct. App. 2017).

Opinion

MARY J. BOYLE, J.:

{¶ 1} The central question we are called upon to answer is whether, under R.C. 2735.01, a trial court may grant an ex parte emergency motion to appoint a receiver to manage and operate an Ohio limited liability company. 1

{¶ 2} In this case, plaintiffs-appellants, Troy Leight and John Nail (collectively "appellants"), appeal from the trial court's judgment granting the emergency motion of defendant-appellee Susan Zull, administrator of the estate of Cynthia Brogan, to appoint a receiver to manage and operate the business of Osteosymbionics, L.L.C. ("Osteo"). On appeal, appellants raise the following assignments of error:

1. An ex parte receivership is improper.
2. An ex parte receivership is unconstitutional.
3. The receivership was invalid because the executrix is not an owner.
4. [The] estate had no damage.
5. The trial court has acted inconsistently with this appellate jurisdiction.
6. [The] bond is inadequate.

{¶ 3} Because we find that Ohio law permits the granting of an emergency ex parte motion to appoint a receiver and the facts of this case justified the trial court's judgment without providing notice and holding an evidentiary hearing, we affirm and remand to the lower court for further proceedings.

I. Procedural History and Facts

{¶ 4} In October 2006, appellants and Cynthia Brogan entered into an Operating Agreement to form Osteo-an Ohio limited liability company in the business of manufacturing medical devices, primarily cranial implants. Osteo's implants benefit patients in need of brain surgeries.

{¶ 5} In March 2014, "Brogan, acting alone, signed an Amended and Restated Operating Agreement," which amended the Operating Agreement in several ways. Leight v. Osteosymbionics, 8th Dist. Cuyahoga No. 102869, 2016-Ohio-110 , 2016 WL 193511 , ¶ 11. Specifically, the Amended and Restated Operating Agreement eliminated "the Board of Managers, making Brogan the sole Manager, vesting the Manager with 'full, exclusive, and complete discretion, power, and authority * * * to manage, control, administer, and operate the business and affairs of the Company,' and giving the Manager irrevocable power of attorney over all members." Id. at ¶ 12. In addition, the Amended and Restated Operating Agreement added an arbitration clause. Id.

{¶ 6} On November 14, 2014, appellants filed their complaint against Osteo and Brogan for breach of fiduciary duty, fraud, civil conspiracy, freeze out, accounting, and injunctive relief. Appellants alleged that "Brogan mismanaged and improperly exercised control over the L.L.C., including 'attempt[ing] to unilaterally change the operating agreement and governing documents of the Company to benefit herself.' " Leight at ¶ 13.

{¶ 7} In response to the complaint, Brogan filed a motion to dismiss the complaint or, in the alternative, to compel arbitration. The trial court denied Brogan's motion, and she appealed to this court. On January 14, 2016, we affirmed the trial court's denial of Brogan's motion to dismiss. See Leight .

{¶ 8} Prior to our decision, however, Brogan died on August 31, 2015. At the request of appellants, the trial court substituted Zull as a party for Brogan because Zull had been appointed the administrator of Brogan's estate.

{¶ 9} On June 17, 2016, appellants and Zull, on behalf of Brogan's estate, entered into a settlement agreement that allowed Leight to "operate and have full authority to operate the business" of Osteo for a period of 120 days (the "Standstill Period"). During the Standstill Period, Zull agreed to "cooperate and use best efforts to aid Leight in the transfer of operations of the business, including, without limitation, finances, banking, orders, access, computer access, customer service, production, IP and IT."

{¶ 10} In addition, during the Standstill Period, Leight agreed to provide to Zull, as administrator of Brogan's estate, "monthly reports as to the operations of [Osteo], * * * including sales efforts, orders, revenue, expenses and liabilities of [Osteo]." Leight also agreed to provide "all information reasonably requested from Leight concerning the operations of [Osteo] during the standstill period" and to "make best efforts to operate [Osteo] as a going concern to preserve the value of [Osteo] and its assets."

{¶ 11} Leight further agreed to use his "best efforts during said 120 day standstill to investigate the allegations of the Lawsuit and any misconduct by [Brogan]." According to the settlement agreement, if Leight "[wa]s satisfied at its sole choice, determination and election as to its investigation that there was no misconduct, then Leight shall pay the [sic] Brogan $20,000.00 for all units owned or previously owned by [Brogan] and her Estate and the parties shall then be released in accordance with Section 3, below." If, however, Leight determined "that there was misconduct or improprieties with the business, then Leight shall provide written notice of that determination to Brogan, no payment shall be made, the Lawsuit shall become active and there shall be no release by or between the parties under this Agreement."

{¶ 12} The parties also agreed that "[n]othing in this [Settlement] Agreement shall be construed as an agreement by Brogan that Leight is authorized to operate [Osteo] beyond the standstill period or to give greater rights to Leight to operate [Osteo] beyond the standstill period."

{¶ 13} Effective June 17, 2016, Leight began to operate Osteo during the Standstill Period. According to a memorandum from Zull's attorney, however, Leight failed to deliver Osteo's financial reports until August 9, 2016. Although these financial reports were not made a part of the trial court record, Zull claimed that they showed that Osteo had a balance of $79,111.83 in its checking account as of the end of July 2016.

{¶ 14} Zull also believed that Leight provided incomplete financial reports for Osteo. Therefore, on August 16, 2016, Zull's attorney emailed Leight's attorney and attached a memorandum with nine initial questions regarding the financial reports. The email stated that "we tried to remain focused on the primary issues. My client does not waive her right to ask for any more information or any other rights she has."

{¶ 15} Within hours of this email on August 16, 2016, Leight's attorney responded, "We are terminating the settlement and returning the case to active litigation. Additionally, due to the manner the company was run prior to my client's recent involvement, there is a massive negative balance. My client is making a capital call of $150,000. Please let me know who I should be contacting."

{¶ 16} In response, on September 1, 2016, Zull's attorney sent correspondence to Leight's attorney reminding him that:

[Brogan] is still the majority owner of [Osteo].

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Fannie Mae v. Clarkwood Apts., L.P.
2025 Ohio 5221 (Ohio Court of Appeals, 2025)
Reese v. Deuer
2025 Ohio 1205 (Ohio Court of Appeals, 2025)
Haber Polk Kabat, L. L.P. v. Condominiums At Stonebridge Owners' Ass'n, Inc.
98 N.E.3d 1172 (Court of Appeals of Ohio, Eighth District, Cuyahoga County, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
2017 Ohio 5749, 94 N.E.3d 995, Counsel Stack Legal Research, https://law.counselstack.com/opinion/leight-v-osteosymbionics-llc-ohioctapp-2017.